The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation

Elevated signature of a gene module coexpressed with CDC20 marks genomic instability in glioma

(2019) Yunqiu Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation

(2019) David W. Ellison et al.   ACTA NEUROPATHOLOGICA

Spinal cord high-grade infiltrating gliomas in adults: clinico-pathological and molecular evaluation

(2019) Mohammed Ali Alvi et al.   MODERN PATHOLOGY

Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma

(2019) Rui-Chao Chai et al.   CARCINOGENESIS

H3 K27M-mutant glioma: Clinical Characteristics and Outcomes

(2019) Tianwei Wang et al.   NEURO-ONCOLOGY

Diffuse midline glioma with an H3 K27M mutation: A comparison integrating the clinical, radiological, molecular features between adult and pediatric patients

(2019) Haihui Jiang et al.   NEURO-ONCOLOGY

cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant

(2018) David N. Louis et al.   ACTA NEUROPATHOLOGICA

H3 K27M–mutant diffuse midline gliomas in different anatomical locations

(2018) Leiming Wang et al.   HUMAN PATHOLOGY

Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries

(2018) Lindsey M. Hoffman et al.   JOURNAL OF CLINICAL ONCOLOGY

Adult Brainstem Gliomas With H3K27M Mutation: Radiology, Pathology, and Prognosis

(2018) Elena V Daoud et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Duplications of KIAA1549 and BRAF screening by Droplet Digital PCR from formalin-fixed paraffin-embedded DNA is an accurate alternative for KIAA1549-BRAF fusion detection in pilocytic astrocytomas

(2018) Romain Appay et al.   MODERN PATHOLOGY

cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

(2018) Daniel J. Brat et al.   ACTA NEUROPATHOLOGICA

Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA

(2018) Changcun Pan et al.   ACTA NEUROPATHOLOGICA

Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor

(2018) Huimin Hu et al.   CELL

A novel analytical model of MGMT methylation pyrosequencing offers improved predictive performance in patients with gliomas

(2018) Rui-Chao Chai et al.   MODERN PATHOLOGY

Transcriptomic and epigenetic profiling of ‘diffuse midline gliomas, H3 K27M-mutant’ discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location

(2018) David Castel et al.   Acta Neuropathologica Communications

Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location

(2017) Michael Karremann et al.   NEURO-ONCOLOGY

Recent advances in intradural spinal tumors

(2017) Muhammad M Abd-El-Barr et al.   NEURO-ONCOLOGY

Diffuse intrinsic pontine gliomas—current management and new biologic insights. Is there a glimmer of hope?

(2017) Kenneth J. Cohen et al.   NEURO-ONCOLOGY

Characteristics of H3 K27M-mutant gliomas in adults

(2017) David Meyronet et al.   NEURO-ONCOLOGY

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant

(2017) Rouzbeh Banan et al.   Acta Neuropathologica Communications

Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology

(2016) Ibrahim Qaddoumi et al.   ACTA NEUROPATHOLOGICA

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

CGCG clinical practice guidelines for the management of adult diffuse gliomas

(2016) Tao Jiang et al.   CANCER LETTERS

Classification based on mutations ofTERTpromoter andIDHcharacterizes subtypes in grade II/III gliomas

(2016) Pei Yang et al.   NEURO-ONCOLOGY

BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histology

(2015) Ganesh M. Shankar et al.   ACTA NEUROPATHOLOGICA

Spinal cord tumours: advances in genetics and their implications for treatment

(2013) Patricia L. Zadnik et al.   Nature Reviews Neurology

Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas

(2012) Benjamin Ellezam et al.   ACTA NEUROPATHOLOGICA

K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas

(2012) Dong-Anh Khuong-Quang et al.   ACTA NEUROPATHOLOGICA

Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology

(2012) A. K. Gnekow et al.   NEURO-ONCOLOGY

IDH1andIDH2Mutations in Gliomas

(2009) Hai Yan et al.   NEW ENGLAND JOURNAL OF MEDICINE